Press-release for stocks for gilead sciences, inc.

Prices are updated after-hours

Second Genome Appoints Joseph Dal Porto, Ph.D., as Chief Scientific Officer
Published: 2022-01-19 (Crawled : 13:00) - biospace.com/
GILD | $67.07 0.06% 0.06% 8.3M

| -6.1% | O: -1.62% H: 0.53% C: -1.72%

| -6.72% | O: -0.65% H: 0.0% C: 0.0%
GLPG | News | $28.78 -2.28% -2.33% 140K

| -47.87% | O: 1.69% H: 0.0% C: 0.0%
jyseleca treatment license ulcerative colitis

62%

38%

CSSE 4 | $0.4323 183.85% 64.77% 220M

BOF | $1.99 70.09% 41.21% 110M

ILAG | $0.51 6.03% 40.62% 1.7M

LICN | $0.941 68.04% 40.49% 15M

AMST | $3.31 65.5% 39.58% 70M

MTC | $3.615 61.38% 38.04% 9.3M

WIMI | $1.15 58.53% 36.92% 19M

AIH | $0.45 12.5% 30.92% 320K

MULN | News | $3.78 38.46% 27.78% 13M

RILY | $29.86 37.48% 27.26% 12M

Save your searches and get alerts when important news are released.